Logo - International Journal of Pharmaceutical Compounding

Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2019 - Volume 23, Number 2
View All Articles in Issue

Abstract:  A formulation for preparing Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, captopril, formulation, angiotensin-converting enzyme inhibitor, ACE inhibitor, hypertension, high blood pressure, congestive heart failure, myocardial infarction, heart attack, left ventricular dysfunction, diabetic nephropathy

Related Categories: FORMULATIONS, CARDIOLOGY

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=4588

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products